IARC verdict: excess body fat causes 13 cancers
An IARC working group reviewed over 1,000 studies and concluded there is sufficient evidence that absence of excess body fat lowers the risk of 13 cancers, up from 5 in the 2002 evaluation.
The International Agency for Research on Cancer convened a working group in 2016 to re-evaluate body fatness and cancer for the IARC Handbooks of Cancer Prevention, reviewing more than 1,000 epidemiological studies, mostly cohort studies, plus mechanistic evidence on insulin, sex hormones and inflammation.
Sufficient evidence of a cancer-preventive effect of avoiding excess body fat was found for cancers of the oesophagus (adenocarcinoma), gastric cardia, colon and rectum, liver, gallbladder, pancreas, breast (postmenopausal), corpus uteri, ovary, kidney (renal cell), meningioma, thyroid and multiple myeloma. Relative risks rose with BMI, ranging from about 1.1 per 5 BMI units for postmenopausal breast cancer to around 7 for endometrial cancer at BMI 40 or above.
The paper reframed obesity as a leading modifiable cancer cause after tobacco.
- Thirteen cancers with sufficient evidence, up from five (colon, oesophagus, kidney, breast, endometrium) in 2002
- Strongest associations: endometrial cancer (RR about 7.1 for BMI 40 or more) and oesophageal adenocarcinoma (RR 4.8)
- Colorectal cancer RR 1.3 and postmenopausal breast cancer RR 1.1 for the highest BMI category studied
- Evidence in children and young adults suggests early-life body fatness raises adult cancer risk
Maintaining a healthy weight is now established cancer prevention for over a dozen cancer types. For clinicians and policymakers, obesity belongs alongside tobacco and alcohol in prevention strategy. Whether intentional weight loss in adulthood reverses risk is still being studied, including in trials of GLP-1 drugs.
- Evidence is observational; residual confounding (diet, activity, socioeconomic status) cannot be excluded
- BMI is a crude measure of body fat; central adiposity may matter more
- Whether losing weight lowers risk is inferred, mainly from bariatric surgery cohorts
- Relative risks for several cancers are modest even though population-attributable fractions are large
Pages like this
not linked directly; found by shared links- TermObesity-related cancers (IARC list of 13)
Shares International Agency for Research on Cancer (IARC / WHO), Thyroid cancer, Endometrial cancer, Prevention we already have is not deployed.
- IdeaLink bariatric and GLP-1 registries to cancer registries in every country that has both
Shares A trial of GLP-1 weight-loss drugs with cancer as the primary outcome, Endometrial cancer, Prevention we already have is not deployed, Renal cell carcinoma.
- TechnologyGLP-1 receptor agonists and obesity-related cancer risk
Shares A trial of GLP-1 weight-loss drugs with cancer as the primary outcome, Funding follows fashion, not burden, Endometrial cancer, Prevention we already have is not deployed.
- TermAlcohol-attributable cancer
Shares International Agency for Research on Cancer (IARC / WHO), Prevention we already have is not deployed, Oesophageal cancer, Hepatocellular carcinoma.
- Key paperAlcohol caused an estimated 741,000 cancers worldwide in 2020
Shares International Agency for Research on Cancer (IARC / WHO), Prevention we already have is not deployed, Oesophageal cancer, Hepatocellular carcinoma.
- TechnologyBariatric surgery and cancer incidence
Shares Endometrial cancer, Prevention we already have is not deployed, Renal cell carcinoma, Hepatocellular carcinoma.
- InstitutionCancer Institute of Iran, Imam Khomeini Hospital Complex
Shares International Agency for Research on Cancer (IARC / WHO), Oesophageal cancer, Gastric & gastro-oesophageal junction cancer, HR-positive / HER2-negative breast cancer.
- TechnologyAlcohol reduction, pricing and cancer warning labels
Shares International Agency for Research on Cancer (IARC / WHO), Prevention we already have is not deployed, Oesophageal cancer, Hepatocellular carcinoma.